fda announcement semaglutide New Weight Loss Medication Wegovy™ Approved by the FDA Approves Semaglutide for New

Frequently Asked Questions About GLP-1s Is Ozempic a GLP-1

J Gastroenterol

Minimize joint pain: Regular strength training and low-impact exercise can go a long way in protecting your joints

Thyroid 31(1):96105

Retatrutide Structure and Chemistry Retatrutide builds on the engineering principles refined in semaglutide and tirzepatide: Glucagon-based peptide backbone retatrutide is derived from glucagon, with modifications to give it activity at all three target receptors Strategic amino acid substitutions multiple substitutions tune the receptor activity balance across GLP-1R, GIPR, and glucagon receptor Fatty acid chain attached for albumin binding and extended half-life (similar strategy to semaglutide and tirzepatide) Aminoisobutyric acid substitutions protect against DPP-4 enzymatic degradation The triple-agonist design is technically demanding because each receptor has different binding requirements

doi:10.1007/s00198-015-3123-0 Wikarek A, Grabarczyk M, Klimek K, Janoska-Gawroska A, Suchodolska M, Holecki M